EPZM Annual CAPEX
$486.00 K
-$50.39 M-99.04%
31 December 2021
Summary:
As of February 5, 2025, EPZM annual capital expenditures is $486.00 thousand, with the most recent change of -$50.39 million (-99.04%) on December 31, 2021. During the last 3 years, it has risen by +$187.00 thousand (+62.54%).EPZM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EPZM Quarterly CAPEX
$0.00
-$10.00 K-100.00%
30 June 2022
Summary:
As of February 5, 2025, EPZM quarterly capital expenditures is $0.00, with the most recent change of -$10.00 thousand (-100.00%) on June 30, 2022. Over the past year, it has dropped by -$102.00 thousand (-100.00%).EPZM Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EPZM TTM CAPEX
$275.00 K
-$102.00 K-27.06%
30 June 2022
Summary:
As of February 5, 2025, EPZM TTM capital expenditures is $275.00 thousand, with the most recent change of -$102.00 thousand (-27.06%) on June 30, 2022. Over the past year, it has dropped by -$497.00 thousand (-64.38%).EPZM TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EPZM CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -99.0% | -100.0% | -64.4% |
| 3 y3 years | +62.5% | -100.0% | -53.7% |
| 5 y5 years | -50.6% | -100.0% | -53.7% |
EPZM CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -99.0% | -100.0% | -99.5% |
Epizyme CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | $0.00(-100.0%) | $275.00 K(-27.1%) |
| Mar 2022 | - | $10.00 K(-89.9%) | $377.00 K(-22.4%) |
| Dec 2021 | $486.00 K(-99.0%) | $99.00 K(-40.4%) | $486.00 K(-27.8%) |
| Sept 2021 | - | $166.00 K(+62.7%) | $673.00 K(-12.8%) |
| June 2021 | - | $102.00 K(-14.3%) | $772.00 K(-97.0%) |
| Mar 2021 | - | $119.00 K(-58.4%) | $25.94 M(-49.0%) |
| Dec 2020 | $50.88 M(+8465.7%) | $286.00 K(+7.9%) | $50.88 M(+0.2%) |
| Sept 2020 | - | $265.00 K(-99.0%) | $50.77 M(+0.1%) |
| June 2020 | - | $25.27 M(+0.8%) | $50.73 M(+97.9%) |
| Mar 2020 | - | $25.06 M(>+9900.0%) | $25.64 M(+4215.8%) |
| Dec 2019 | $594.00 K(+98.7%) | $171.00 K(-26.6%) | $594.00 K(+4.2%) |
| Sept 2019 | - | $233.00 K(+37.9%) | $570.00 K(+50.0%) |
| June 2019 | - | $169.00 K(+704.8%) | $380.00 K(+79.2%) |
| Mar 2019 | - | $21.00 K(-85.7%) | $212.00 K(-29.1%) |
| Dec 2018 | $299.00 K(-69.6%) | $147.00 K(+241.9%) | $299.00 K(-25.1%) |
| Sept 2018 | - | $43.00 K(+4200.0%) | $399.00 K(-2.7%) |
| June 2018 | - | $1000.00(-99.1%) | $410.00 K(-57.9%) |
| Mar 2018 | - | $108.00 K(-56.3%) | $974.00 K(-1.0%) |
| Dec 2017 | $984.00 K | $247.00 K(+357.4%) | $984.00 K(+4.6%) |
| Sept 2017 | - | $54.00 K(-90.4%) | $941.00 K(-4.8%) |
| June 2017 | - | $565.00 K(+378.8%) | $988.00 K(+47.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | $118.00 K(-42.2%) | $672.00 K(+7.7%) |
| Dec 2016 | $624.00 K(-98.4%) | $204.00 K(+102.0%) | $624.00 K(+50.4%) |
| Sept 2016 | - | $101.00 K(-59.4%) | $415.00 K(+52.0%) |
| June 2016 | - | $249.00 K(+255.7%) | $273.00 K(+203.3%) |
| Mar 2016 | - | $70.00 K(-1500.0%) | $90.00 K(-99.8%) |
| Dec 2015 | $40.18 M(+1713.3%) | -$5000.00(-87.8%) | $40.18 M(-2.4%) |
| Sept 2015 | - | -$41.00 K(-162.1%) | $41.17 M(-1.1%) |
| June 2015 | - | $66.00 K(-99.8%) | $41.62 M(-1.1%) |
| Mar 2015 | - | $40.16 M(+3973.3%) | $42.06 M(+1798.1%) |
| Dec 2014 | $2.22 M(+251.7%) | $986.00 K(+142.9%) | $2.22 M(+36.0%) |
| Sept 2014 | - | $406.00 K(-20.1%) | $1.63 M(+33.2%) |
| June 2014 | - | $508.00 K(+60.8%) | $1.22 M(+35.1%) |
| Mar 2014 | - | $316.00 K(-21.0%) | $906.00 K(+43.8%) |
| Dec 2013 | $630.00 K(-57.5%) | $400.00 K(>+9900.0%) | $630.00 K(-57.2%) |
| Sept 2013 | - | $0.00(-100.0%) | $1.47 M(-0.5%) |
| June 2013 | - | $190.00 K(+375.0%) | $1.48 M(+13.8%) |
| Mar 2013 | - | $40.00 K(-96.8%) | $1.30 M(-12.2%) |
| Dec 2012 | $1.48 M(+61.4%) | $1.24 M(>+9900.0%) | $1.48 M(+520.1%) |
| Sept 2012 | - | $7000.00(-36.4%) | $239.00 K(+3.0%) |
| June 2012 | - | $11.00 K(-95.0%) | $232.00 K(+5.0%) |
| Mar 2012 | - | $221.00 K | $221.00 K |
| Dec 2011 | $918.00 K | - | - |
FAQ
- What is Epizyme annual capital expenditures?
- What is the all time high annual CAPEX for Epizyme?
- What is Epizyme annual CAPEX year-on-year change?
- What is Epizyme quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Epizyme?
- What is Epizyme quarterly CAPEX year-on-year change?
- What is Epizyme TTM capital expenditures?
- What is the all time high TTM CAPEX for Epizyme?
- What is Epizyme TTM CAPEX year-on-year change?
What is Epizyme annual capital expenditures?
The current annual CAPEX of EPZM is $486.00 K
What is the all time high annual CAPEX for Epizyme?
Epizyme all-time high annual capital expenditures is $50.88 M
What is Epizyme annual CAPEX year-on-year change?
Over the past year, EPZM annual capital expenditures has changed by -$50.39 M (-99.04%)
What is Epizyme quarterly capital expenditures?
The current quarterly CAPEX of EPZM is $0.00
What is the all time high quarterly CAPEX for Epizyme?
Epizyme all-time high quarterly capital expenditures is $40.16 M
What is Epizyme quarterly CAPEX year-on-year change?
Over the past year, EPZM quarterly capital expenditures has changed by -$102.00 K (-100.00%)
What is Epizyme TTM capital expenditures?
The current TTM CAPEX of EPZM is $275.00 K
What is the all time high TTM CAPEX for Epizyme?
Epizyme all-time high TTM capital expenditures is $50.88 M
What is Epizyme TTM CAPEX year-on-year change?
Over the past year, EPZM TTM capital expenditures has changed by -$497.00 K (-64.38%)